Medical economics

Brand drug discount cards increase private insurer costs by 46%

Discount cards for brand-name drugs provided to patients increased private insurer costs by 46% and varied in their impact on out-of-pocket payments by patients, found new research in CMAJ (Canadian Medical Association Journal).

Medications

Expert: Opioid settlements come with limitations

The nation's three biggest drug distributors and a major drugmaker agreed to a $260 million settlement Monday over the toll taken by opioids in two Ohio counties, averting the first federal trial over the crisis.

Oncology & Cancer

Cost burden of disease progression high in multiple myeloma

(HealthDay)—The economic burden of disease progression is considerable among multiple myeloma (MM) patients receiving drug therapy across all lines of therapy (LOTs), according to a study published online Aug. 7 in Leukemia ...

page 24 from 40